Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins.
about
Exotoxins of Staphylococcus aureusPanton-valentine leukocidin and staphyloccoccal skin infections in schoolchildrenPanton-Valentine leukocidin genes in Staphylococcus aureusPathogenesis of methicillin-resistant Staphylococcus aureus infectionResidues Essential for Panton-Valentine Leukocidin S Component Binding to Its Cell Receptor Suggest Both Plasticity and Adaptability in Its Interaction SurfacePanton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit modelStaphylococcal Panton-Valentine leucocidin as a major virulence factor associated to furuncles.Ion channels and bacterial infection: the case of beta-barrel pore-forming protein toxins of Staphylococcus aureus.The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.Unusually high prevalence of panton-valentine leukocidin genes among methicillin-sensitive Staphylococcus aureus strains carried in the Indonesian population.Factors predicting and reducing mortality in patients with invasive Staphylococcus aureus disease in a developing countryA histidine-to-arginine substitution in Panton-Valentine leukocidin from USA300 community-acquired methicillin-resistant Staphylococcus aureus does not impair its leukotoxicity.Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin.Rapid detection of Staphylococcus aureus Panton-Valentine leukocidin in clinical specimens by enzyme-linked immunosorbent assay and immunochromatographic testsStaphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease.Frequent carriage of Panton-Valentine leucocidin genes by Staphylococcus aureus isolates from surgically drained abscesses.Breast milk transmission of a Panton-Valentine leukocidin-producing Staphylococcus aureus strain causing infantile pneumoniaDifferent clonal complexes of methicillin-resistant Staphylococcus aureus are disseminated in the Euregio Meuse-Rhine regionProstatic abscesses and severe sepsis due to methicillin-susceptible Staphylococcus aureus producing Panton-Valentine leukocidincontribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections.Recurrent furunculosis: a review of the literature.The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptorsVariability of antibiotic susceptibility and toxin production of Staphylococcus aureus strains isolated from skin, soft tissue, and bone related infections.Engineering of the LukS-PV and LukF-PV subunits of Staphylococcus aureus Panton-Valentine leukocidin for diagnostic and therapeutic applications.Genetic diversity of Staphylococcus aureus in Buruli ulcer.Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities.Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin PairsMethicillin-resistant Staphylococcus aureus in children, Taiwan.Patients with Panton-Valentine leukocidin positive Staphylococcus aureus infections run an increased risk of longer hospitalisation.Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a ReceptorsMolecular diagnostics of clinically important staphylococci.Do differences in Panton-Valentine leukocidin production among international methicillin-resistant Staphylococcus aureus clones affect disease presentation and severity?Crystallization and preliminary crystallographic studies of both components of the staphylococcal LukE-LukD leukotoxin.Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse ErythrocytesPrevention of Staphylococcus aureus infections: advances in vaccine development.Necrotizing pneumonia caused by Panton-Valentine leucocidin-producing Staphylococcus aureus originating from a Bartholin's abscess.Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus
P2860
Q24550718-A746983F-AA94-4AF7-B527-1EDF330EEFC7Q24600307-5606C65A-DA95-47CB-AB36-5E53D2350B97Q24603808-0616728B-9246-49A5-8AF1-2EABDD38A834Q24657579-0D115467-4601-4EE6-9AEF-921429B71709Q27682292-0B2A1A43-A530-4476-9124-16EA80A42430Q28741721-D45AFF4F-ADA7-40B1-92E4-6D7163894314Q30155449-2A0DE5F2-EC86-4B83-A1D7-5D29C2290C41Q30164517-B24108EF-5A0B-48AF-8741-E96A4100DCABQ30415990-9A989883-A1CC-40BF-8180-A8C5D98E3D25Q33264579-24482CA3-73CB-47B2-BED2-8B6363B464E5Q33330592-F9D8C55A-6E21-4D34-A146-7D20BE96CC34Q33490115-C82C1BFA-36BB-4578-AE4F-29656B5B1A80Q33557856-6FA5A0CB-A234-40F8-8133-31DB773760B7Q33715923-37A0AA86-6503-4877-9305-60B6CD3DED5FQ33769542-1ECC293A-B0AA-48E8-8FB0-FF65A4E432DDQ33858913-E4A9DFA5-5AC8-4F7B-A10D-69B75DEEBD9BQ33885221-887127A7-73CC-49EE-ACC7-E775AA1612BEQ33971325-2AC11EAA-2200-4D54-BE6C-A73AA3C45942Q34076983-0DF706FE-1038-45D0-8B05-C5C21EA82DAFQ34143887-05BB31BD-CD64-49DB-8E6F-D841FB15B5C2Q34245797-CE132370-DA36-4596-A5A7-9360CFE9DE15Q34288629-CA360C22-86B9-496D-AEEB-1E70704395FAQ34353754-3D57F2B1-2AC5-427D-B2C8-CD436476B16DQ34478074-60285F4F-8405-44CE-9946-BF6CB895E18EQ34495209-6A4DB79E-A970-4C41-9120-D8AC83396019Q34909005-7B6F05A2-1CB0-4657-9FB1-F6F3765D1ECCQ35047035-F30D6379-3DD1-4F94-8099-0A58FD789781Q35058098-99E373AE-8E79-4C88-8459-4820CB223F05Q35445793-907599AA-0280-4A25-977A-3913828F2272Q35772579-1101EFCA-29FD-4F0F-BFAE-7E1693EC6464Q35793200-814336C2-8101-4397-B107-00E5225E0B62Q35862697-1D52BEC5-3691-4684-8A14-9FEF403497E6Q35864500-02211EDB-8BBE-4626-B0D6-1133C6CED2DEQ35941369-AD0FFD75-31FA-4412-BBB5-8CE541144E5FQ35942838-79AD352E-1FC6-4ECE-B482-8EA8B4B6B011Q36019218-D2B9ABD7-D3DE-4873-A75E-06BCE23F0A82Q36081594-89E1D738-0200-4DAC-91DA-C50D9885ED9DQ36284548-42130D89-EACA-41DA-B3BB-54157909AE4CQ36801967-EAE949E6-DE6C-4180-9A24-EF06FEA48BCBQ37083679-36D15E34-D2F8-47F1-9706-299C24A79A48
P2860
Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Epidemiological data on Staphy ...... ng synergohymenotropic toxins.
@ast
Epidemiological data on Staphy ...... ng synergohymenotropic toxins.
@en
type
label
Epidemiological data on Staphy ...... ng synergohymenotropic toxins.
@ast
Epidemiological data on Staphy ...... ng synergohymenotropic toxins.
@en
prefLabel
Epidemiological data on Staphy ...... ng synergohymenotropic toxins.
@ast
Epidemiological data on Staphy ...... ng synergohymenotropic toxins.
@en
P2093
P1476
Epidemiological data on Staphy ...... ing synergohymenotropic toxins
@en
P2093
P304
P356
10.1099/00222615-42-4-237
P577
1995-04-01T00:00:00Z